End of Financial Year Appeal 2025

Launching the CAR T-Cell Fighting Fund to Help Children Like Chloe

At just four years old, Chloe has faced more than most of us will in a lifetime. Diagnosed with aggressive neuroblastoma, she has endured some of the harshest and most toxic cancer treatments available.

Her mum, Fiona, shared the heartbreaking reality of Chloe’s journey:

The treatment so far has been aggressive, daunting, confronting and cruel. We understand that this is the only way this horrible disease can be treated. However, it’s so difficult to watch the pain and torture our little girl must go through.

For children like Chloe, these intense treatments are currently the only option. Yet, despite enduring months of chemotherapy, surgery, stem cell transplants and more, the survival rate for children with high-risk neuroblastoma remains at only 50%.

That’s why we’re launching the CAR T-Cell Fighting Fund.

CAR T-cell therapy is a promising new treatment that harnesses a child’s own immune system to find and destroy cancer cells. It has already shown remarkable results in some adult cancers, and we believe it could be a life-changing option for children diagnosed with neuroblastoma.

With your help, we aim to raise $100,000 to support research that will adapt this cutting-edge therapy for children with neuroblastoma in Australia. Our community has already shown what’s possible — thanks to your support, children in Australia now have access to DFMO, a breakthrough maintenance treatment. Now, we’re asking you to help us take the next step.

CAR T-cell therapy could reduce the need for toxic treatments and offer children like Chloe a real chance at a safer, healthier future.

Read Chloe’s full story here:
https://www.neuroblastoma.org.au/blog/chloes-story

Donate today and help us bring better, safer treatments to the children who need them most.